This message was sent to ##Email##
|
|
|
|
|
AST
The 2019 Cutting Edge of Transplantation (CEoT) meeting will be held February 21-23 in Phoenix, Arizona. Join us for this intimate meeting on personalized medicine.
AST
The nomination window for the AST Community of Practice (COP) election is now open. To learn more about the available positions, click here. All nominations must be submitted by February 25.
READ MORE
AST
The newly developed Travel for Techniques in Transplantation Research (T3R) Program supports the travel of a scientist to the laboratory of another scientist to acquire a new technique. This program fulfills a goal of the AST Research Network to facilitate bringing novel, cutting edge techniques to transplant biology research labs and clinical scientists. Recipients will receive up to $2,000 for travel. The deadline to apply is March 15, 2019.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
AST
Spread the word about the benefits of AST membership and help strengthen the Society!
New this year—All members who successfully recruit three new members will receive one future year of membership free! In addition, you will be entered in the yearly prize drawing, which includes an iPad and AST bucks!
Quickly send your colleagues a professional request to join via our easy referral form.
Spread the word! Recommend colleagues for membership and earn rewards. Visit the Member-Get-A-Member page for program details and other resources.
AST
Join thousands of transplant professionals at this year's American Transplant Congress (ATC), June 1–5, 2019, in Boston, Massachusetts. From cutting-edge science that's transforming the field, to in-depth workshops and hot topic sessions, the ATC is quickly becoming the most recognized transplant Congress in the world.
READ MORE
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
OPTN/UNOS
OPTN/UNOS is offering nine proposals for public comment. You are encouraged to post comments on their website during the public comment period that runs January 22 – March 22, 2019. Your voice is important and considered during the OPTN/UNOS policy development process. During the public comment period, UNOS offers national webinars to provide members an opportunity to learn about proposals on the upcoming regional meeting agenda and ask questions of presenters/subject matter experts. For information about these webinars, click here.
The COPs will be reviewing the proposals and providing feedback for the AST's Policy Committee to develop a Society response for Board approval. If you would like to also submit your individual comments to AST for consideration as part of this process, please email them to scovington@myast.org with the subject line PUBLIC COMMENT.
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career—from basic trainee lessons to webinars on specialized topics. LEARN MORE
|
|
AST
Transplant professionals have increasing demands on their time. Finding time in one's day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
| Upcoming Education Events
|
    |
AST
Which Live Donor Kidney is Better?
February 20, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
Geographic disparities in lung transplant rates
March 5, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
Case-Based Multidisciplinary Approach to Cardiac and Pulmonary Vascular Disease Risk Assessment in Liver Transplantation
March 20, 2019 | 2 p.m. ET | Online Activity
For more information, click here.
AST
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2020 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology. The prize consists of a crystal award, an honorarium of $10,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2020 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. The winner will also participate in related activities and meet informally with faculty, post-doctoral fellows and students.
READ MORE
ASTS
The goal of the ASTS Cellular Transplantation Committee is to advance the knowledge and promote clinical and research work in the field of cellular transplantation. One of this year’s initiatives that was set forward by the ASTS Cellular Transplantation Committee is to conduct the survey of ongoing research and clinical work in the areas of cellular products and therapies. The purpose of the project is to assess areas of interest of research within the transplant community. This survey should take approximately 10 minutes.
READ MORE
AST
The abstract submission site is now open for the ASHI/BANFF Joint Scientific Meeting. Abstracts may be accepted for either an oral presentation or a poster presentation.
READ MORE
AST via Wiley Online Library
The Third International Workshop on Clinical Tolerance was held in Stanford, California, September 8–9, 2017. This is a summary of Workshop presentations of clinical trials designed to withdraw or minimize immunosuppressive drugs in kidney and liver transplant patients without subsequent evidence of rejection. All clinical protocols had in common the use of donor or recipient cell therapy combined with organ transplantation.
READ MORE
AST via Wiley Online Library
Currently, the ability to predict or monitor the efficacy of HLA antibody–removal therapies is deficient. We previously reported that titration studies are a consistent and accurate means of assessing antibody strength. To test whether titration studies can also predict which patients are better candidates for desensitization, we studied 38 patients from three centers.
READ MORE
AASLD via Wiley Online Library
Cardiovascular events account for 8 to 13 percent of deaths after liver transplantation in adulthood. Although CV risk factors are present, little is known about the prevalence of subclinical CV target organ damage in children after LT. The aim of this prospective observational study was to assess the prevalence of subclinical CV target organ damage in children after LT and to identify risk factors contributing to CV damage.
READ MORE
AASLD via Wiley Online Library
Highly effective direct acting antiviral therapy has transformed outcomes of liver transplantation in HCV patients. We examined longer‐term outcomes in HCV‐positive recipients in the DAA era.
READ MORE
Transplantation via Wolters Kluwer
Acute cellular rejection in lung transplant recipients requires demonstration of perivascular lymphocytic infiltration in alveolar tissue samples from transbronchial biopsies. Probe-based confocal laser endomicroscopy allows in vivo observation of alveolar, vascular and cellular microstructures in the lung with potential to identify ACR.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
